• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    20.38 Down 0.24(1.16%) May 22, 3:59PM EDT
    Add to Portfolio
    Prev Close:20.62
    Open:20.55
    Bid:0.00 x 100
    Ask:N/A
    1y Target Est:27.17
    Beta:0.08
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:20.12 - 20.80
    52wk Range:19.10 - 36.68
    Volume:428,790
    Avg Vol (3m):565,778
    Market Cap:582.30M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 1.16%582.30M
    AZNDown 0.59%87.78B
    MRKDown 1.20%167.76B
    PFEDown 0.23%211.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.73
    Quarterly EPS Est (Jun-15) :-0.34
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-2.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback